Pfizer and BioNTech: Vaccine against new COVID-19 strain can be produced in 100 days

Published



A vaccine that protects against the omicron variant of COVID-19 could be made within 100 days, Pfizer and BioNTech announced Friday.

Pfizer said it is working to adapt the vaccine and monitoring for emerging strains of the virus, the most recent of which, B.1.1.529, known as “omicron,” was discovered by the World Health Organization in South Africa. BioNTech also said it is monitoring the highly transmissible “variant of concern.”

Trusted reporting.Unlimited access.

Subscribe for full access to Washington Examiner coverage, expert political analysis, and subscriber-only journalism.

Get Unlimited Access

Already a member? Log in

Cancel anytime.